List of Tables
Table 1. Global Personalizing Cancer Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunotherapy
Table 3. Key Players of Targeted Therapy
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Hormone Therapy
Table 6. Key Players of Others
Table 7. Global Personalizing Cancer Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Personalizing Cancer Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Personalizing Cancer Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Personalizing Cancer Drugs Market Share by Regions (2016-2021)
Table 11. Global Personalizing Cancer Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Personalizing Cancer Drugs Market Share by Regions (2022-2027)
Table 13. Personalizing Cancer Drugs Market Trends
Table 14. Personalizing Cancer Drugs Market Drivers
Table 15. Personalizing Cancer Drugs Market Challenges
Table 16. Personalizing Cancer Drugs Market Restraints
Table 17. Global Personalizing Cancer Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Personalizing Cancer Drugs Market Share by Players (2016-2021)
Table 19. Global Top Personalizing Cancer Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalizing Cancer Drugs as of 2020)
Table 20. Ranking of Global Top Personalizing Cancer Drugs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Personalizing Cancer Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Personalizing Cancer Drugs Product Solution and Service
Table 24. Date of Enter into Personalizing Cancer Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Personalizing Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Personalizing Cancer Drugs Revenue Market Share by Type (2016-2021)
Table 28. Global Personalizing Cancer Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Personalizing Cancer Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Personalizing Cancer Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Personalizing Cancer Drugs Revenue Market Share by Application (2016-2021)
Table 32. Global Personalizing Cancer Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Personalizing Cancer Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Personalizing Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Personalizing Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Personalizing Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Personalizing Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Personalizing Cancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Personalizing Cancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Personalizing Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Personalizing Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Personalizing Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Personalizing Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Personalizing Cancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Personalizing Cancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Personalizing Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Personalizing Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Personalizing Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Personalizing Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Personalizing Cancer Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Personalizing Cancer Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Personalizing Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Personalizing Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Personalizing Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Personalizing Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Personalizing Cancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Personalizing Cancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Personalizing Cancer Drugs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Personalizing Cancer Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Personalizing Cancer Drugs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Personalizing Cancer Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Personalizing Cancer Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Personalizing Cancer Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 64. Bayer Company Details
Table 65. Bayer Business Overview
Table 66. Bayer Personalizing Cancer Drugs Product
Table 67. Bayer Revenue in Personalizing Cancer Drugs Business (2016-2021) & (US$ Million)
Table 68. Bayer Recent Development
Table 69. GlaxoSmithKline Company Details
Table 70. GlaxoSmithKline Business Overview
Table 71. GlaxoSmithKline Personalizing Cancer Drugs Product
Table 72. GlaxoSmithKline Revenue in Personalizing Cancer Drugs Business (2016-2021) & (US$ Million)
Table 73. GlaxoSmithKline Recent Development
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Personalizing Cancer Drugs Product
Table 77. Novartis Revenue in Personalizing Cancer Drugs Business (2016-2021) & (US$ Million)
Table 78. Novartis Recent Development
Table 79. Sanofi Company Details
Table 80. Sanofi Business Overview
Table 81. Sanofi Personalizing Cancer Drugs Product
Table 82. Sanofi Revenue in Personalizing Cancer Drugs Business (2016-2021) & (US$ Million)
Table 83. Sanofi Recent Development
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Personalizing Cancer Drugs Product
Table 87. Pfizer Revenue in Personalizing Cancer Drugs Business (2016-2021) & (US$ Million)
Table 88. Pfizer Recent Development
Table 89. Amgen Company Details
Table 90. Amgen Business Overview
Table 91. Amgen Personalizing Cancer Drugs Product
Table 92. Amgen Revenue in Personalizing Cancer Drugs Business (2016-2021) & (US$ Million)
Table 93. Amgen Recent Development
Table 94. Merck Company Details
Table 95. Merck Business Overview
Table 96. Merck Personalizing Cancer Drugs Product
Table 97. Merck Revenue in Personalizing Cancer Drugs Business (2016-2021) & (US$ Million)
Table 98. Merck Recent Development
Table 99. Bristol-Myers Squibb Company Details
Table 100. Bristol-Myers Squibb Business Overview
Table 101. Bristol-Myers Squibb Revenue in Personalizing Cancer Drugs Business (2016-2021) & (US$ Million)
Table 102. Bristol-Myers Squibb Recent Development
Table 103. Celgene Corporation Company Details
Table 104. Celgene Corporation Business Overview
Table 105. Celgene Corporation Personalizing Cancer Drugs Product
Table 106. Celgene Corporation Revenue in Personalizing Cancer Drugs Business (2016-2021) & (US$ Million)
Table 107. Celgene Corporation Recent Development
Table 108. Ariad Pharmaceuticals Company Details
Table 109. Ariad Pharmaceuticals Business Overview
Table 110. Ariad Pharmaceuticals Personalizing Cancer Drugs Product
Table 111. Ariad Pharmaceuticals Revenue in Personalizing Cancer Drugs Business (2016-2021) & (US$ Million)
Table 112. Ariad Pharmaceuticals Recent Development
Table 113. Eli Lilly Company Details
Table 114. Eli Lilly Business Overview
Table 115. Eli Lilly Personalizing Cancer Drugs Product
Table 116. Eli Lilly Revenue in Personalizing Cancer Drugs Business (2016-2021) & (US$ Million)
Table 117. Eli Lilly Recent Development
Table 118. Hoffmann-La Roche Company Details
Table 119. Hoffmann-La Roche Business Overview
Table 120. Hoffmann-La Roche Personalizing Cancer Drugs Product
Table 121. Hoffmann-La Roche Revenue in Personalizing Cancer Drugs Business (2016-2021) & (US$ Million)
Table 122. Hoffmann-La Roche Recent Development
Table 123. Boehringer Ingelheim Company Details
Table 124. Boehringer Ingelheim Business Overview
Table 125. Boehringer Ingelheim Personalizing Cancer Drugs Product
Table 126. Boehringer Ingelheim Revenue in Personalizing Cancer Drugs Business (2016-2021) & (US$ Million)
Table 127. Boehringer Ingelheim Recent Development
Table 128. Johnson and Johnson Company Details
Table 129. Johnson and Johnson Business Overview
Table 130. Johnson and Johnson Personalizing Cancer Drugs Product
Table 131. Johnson and Johnson Revenue in Personalizing Cancer Drugs Business (2016-2021) & (US$ Million)
Table 132. Johnson and Johnson Recent Development
Table 133. Teva Pharmaceuticals Company Details
Table 134. Teva Pharmaceuticals Business Overview
Table 135. Teva Pharmaceuticals Personalizing Cancer Drugs Product
Table 136. Teva Pharmaceuticals Revenue in Personalizing Cancer Drugs Business (2016-2021) & (US$ Million)
Table 137. Teva Pharmaceuticals Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Personalizing Cancer Drugs Market Share by Type: 2020 VS 2027
Figure 2. Immunotherapy Features
Figure 3. Targeted Therapy Features
Figure 4. Chemotherapy Features
Figure 5. Hormone Therapy Features
Figure 6. Others Features
Figure 7. Global Personalizing Cancer Drugs Market Share by Application: 2020 VS 2027
Figure 8. Breast Cancer Case Studies
Figure 9. Blood Cancer Case Studies
Figure 10. Gastrointestinal Cancer Case Studies
Figure 11. Prostate Cancer Case Studies
Figure 12. Skin Cancer Case Studies
Figure 13. Lung Cancer Case Studies
Figure 14. Others Case Studies
Figure 15. Personalizing Cancer Drugs Report Years Considered
Figure 16. Global Personalizing Cancer Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Personalizing Cancer Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Personalizing Cancer Drugs Market Share by Regions: 2020 VS 2027
Figure 19. Global Personalizing Cancer Drugs Market Share by Regions (2022-2027)
Figure 20. Global Personalizing Cancer Drugs Market Share by Players in 2020
Figure 21. Global Top Personalizing Cancer Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Personalizing Cancer Drugs as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Personalizing Cancer Drugs Revenue in 2020
Figure 23. Global Personalizing Cancer Drugs Revenue Market Share by Type (2016-2021)
Figure 24. Global Personalizing Cancer Drugs Revenue Market Share by Type (2022-2027)
Figure 25. North America Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Personalizing Cancer Drugs Market Share by Type (2016-2027)
Figure 27. North America Personalizing Cancer Drugs Market Share by Application (2016-2027)
Figure 28. North America Personalizing Cancer Drugs Market Share by Country (2016-2027)
Figure 29. United States Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Personalizing Cancer Drugs Market Share by Type (2016-2027)
Figure 33. Europe Personalizing Cancer Drugs Market Share by Application (2016-2027)
Figure 34. Europe Personalizing Cancer Drugs Market Share by Country (2016-2027)
Figure 35. Germany Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Personalizing Cancer Drugs Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Personalizing Cancer Drugs Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Personalizing Cancer Drugs Market Share by Region (2016-2027)
Figure 45. China Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Personalizing Cancer Drugs Market Share by Type (2016-2027)
Figure 53. Latin America Personalizing Cancer Drugs Market Share by Application (2016-2027)
Figure 54. Latin America Personalizing Cancer Drugs Market Share by Country (2016-2027)
Figure 55. Mexico Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Personalizing Cancer Drugs Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Personalizing Cancer Drugs Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Personalizing Cancer Drugs Market Share by Country (2016-2027)
Figure 61. Turkey Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Personalizing Cancer Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Bayer Revenue Growth Rate in Personalizing Cancer Drugs Business (2016-2021)
Figure 65. GlaxoSmithKline Revenue Growth Rate in Personalizing Cancer Drugs Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Personalizing Cancer Drugs Business (2016-2021)
Figure 67. Sanofi Revenue Growth Rate in Personalizing Cancer Drugs Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Personalizing Cancer Drugs Business (2016-2021)
Figure 69. Amgen Revenue Growth Rate in Personalizing Cancer Drugs Business (2016-2021)
Figure 70. Merck Revenue Growth Rate in Personalizing Cancer Drugs Business (2016-2021)
Figure 71. Bristol-Myers Squibb Revenue Growth Rate in Personalizing Cancer Drugs Business (2016-2021)
Figure 72. Celgene Corporation Revenue Growth Rate in Personalizing Cancer Drugs Business (2016-2021)
Figure 73. Ariad Pharmaceuticals Revenue Growth Rate in Personalizing Cancer Drugs Business (2016-2021)
Figure 74. Eli Lilly Revenue Growth Rate in Personalizing Cancer Drugs Business (2016-2021)
Figure 75. Hoffmann-La Roche Revenue Growth Rate in Personalizing Cancer Drugs Business (2016-2021)
Figure 76. Boehringer Ingelheim Revenue Growth Rate in Personalizing Cancer Drugs Business (2016-2021)
Figure 77. Johnson and Johnson Revenue Growth Rate in Personalizing Cancer Drugs Business (2016-2021)
Figure 78. Teva Pharmaceuticals Revenue Growth Rate in Personalizing Cancer Drugs Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed

LIST OF FIGURE